These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

48 related items for PubMed ID: 2057019

  • 21. Influence of peritoneal dialysis training nurses' experience on peritonitis rates.
    Chow KM, Szeto CC, Law MC, Fun Fung JS, Kam-Tao Li P.
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):647-52. PubMed ID: 17699477
    [Abstract] [Full Text] [Related]

  • 22. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL, Moles K, Pope K, Hargrove P.
    Adv Perit Dial; 2000 Jul; 16():280-4. PubMed ID: 11045311
    [Abstract] [Full Text] [Related]

  • 23. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.
    de Fijter CW, Verbrugh HA, Peters ED, Oe PL, van der Meulen J, Verhoef J, Donker AJ.
    Clin Nephrol; 1993 Feb; 39(2):75-80. PubMed ID: 8448921
    [Abstract] [Full Text] [Related]

  • 24. Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.
    Verbrugh HA, Keane WF, Conroy WE, Peterson PK.
    J Clin Microbiol; 1984 Aug; 20(2):199-203. PubMed ID: 6386844
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Intracellular survival of Candida albicans in peritoneal macrophages from chronic peritoneal dialysis patients.
    Peterson PK, Lee D, Suh HJ, Devalon M, Nelson RD, Keane WF.
    Am J Kidney Dis; 1986 Feb; 7(2):146-52. PubMed ID: 3004201
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Cytotoxic activity of murine peritoneal cavity cells during inflammation in vivo].
    Sukharev SA, Smirnov SV, Pleshakova OV, Sadovnikov VB.
    Dokl Akad Nauk; 1995 Jul; 343(3):403-5. PubMed ID: 7580980
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Human plasma and the antibacterial effect of peritoneal dialysis solutions.
    Borchardt KA, Richardson JA.
    Br Med J; 1971 Jan 23; 1(5742):205-6. PubMed ID: 5541232
    [Abstract] [Full Text] [Related]

  • 33. Androgen metabolism by human peritoneal macrophages.
    Coddington CC, Letterie GS, Klein TA, Winkel CA.
    Steroids; 1988 Jan 23; 51(1-2):143-61. PubMed ID: 3242165
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Macrophage migration inhibitory activity in the sera of patients undergoing peritoneal dialysis for psoriasis.
    Halevy S, Halevy J, Livni E, Boner G, Rosenfeld JB, Feuerman EJ.
    Arch Dermatol Res; 1982 Jan 23; 274(1-2):73-8. PubMed ID: 6762162
    [Abstract] [Full Text] [Related]

  • 36. New Synthetic Nitro-Pyrrolomycins as Promising Antibacterial and Anticancer Agents.
    Raimondi MV, Presentato A, Li Petri G, Buttacavoli M, Ribaudo A, De Caro V, Alduina R, Cancemi P.
    Antibiotics (Basel); 2020 May 30; 9(6):. PubMed ID: 32486200
    [Abstract] [Full Text] [Related]

  • 37. Bactericidal activity of human peritoneal macrophages from patients undergoing peritoneal dialysis.
    Thomas CA, Interwies EW, Ziegler BL, Vlachojanis J, Kurz P, Shah PM.
    Nat Immun Cell Growth Regul; 1991 May 30; 10(1):12-8. PubMed ID: 2057019
    [Abstract] [Full Text] [Related]

  • 38. The effect of dwell time on peritoneal phagocytic defense of chronic peritoneal dialysis patients.
    Vlaanderen K, de Fijter CW, Bos HJ, van der Meulen J, Beelen RH, Oe PL, Verbrugh HA.
    Adv Perit Dial; 1989 May 30; 5():151-3. PubMed ID: 2577399
    [Abstract] [Full Text] [Related]

  • 39. The antibacterial activity of tramadol against bacteria associated with infectious complications after local or regional anesthesia.
    Tamanai-Shacoori Z, Shacoori V, Jolivet-Gougeon A, Vo Van JM, Repère M, Donnio PY, Bonnaure-Mallet M.
    Anesth Analg; 2007 Aug 30; 105(2):524-7. PubMed ID: 17646517
    [Abstract] [Full Text] [Related]

  • 40. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients.
    McGregor SJ, Brock JH, Briggs JD, Junor BJ.
    Nephrol Dial Transplant; 1987 Aug 30; 2(2):104-8. PubMed ID: 3112647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.